Aller au contenu principal
Profil bibliographique

Jianguo Zhou

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

68Publications signalées
162Citations signalées
6Affiliations récentes

Les institutions déclarées

Les domaines associés

Cancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchNanoparticle-Based Drug DeliveryCancer, Lipids, and MetabolismColorectal Cancer Treatments and Studies

Les publications récentes

Accès ouvert 2026 article OpenAlex

First-line immune checkpoint inhibitors versus chemotherapy in delaying quality of life deterioration in advanced NSCLC: a systematic review and meta-analysis

Juanyan Shen, Junliang Ma, Shaolin Chen, Qisha Li et autres

Backgroud: Immune checkpoint inhibitors (ICIs) have transformed first-line treatment for advanced non–small-cell lung cancer (aNSCLC). While overall survival(OS) remains the primary endpoint, health-related quality of life (HRQoL) is a key patient-centered outcome. Time to deterioration (TTD) captures the durability of HRQoL over …

cn, de (code pays fourni par la source)

0 citations BMC Medicine
Accès ouvert 2026 article OpenAlex

Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study

Huijing Tan, Jianguo Zhou, Susheng Shi, Liming Jiang et autres

Background: Leiomyosarcoma (LMS) is an aggressive soft tissue sarcoma with high rates of hematogenous metastasis and recurrent relapse, with a 5-year survival rate of 17.0%. This study evaluated the clinical efficacy of an anthracycline plus temozolomide (ATEM) regimen in advanced LMS and …

cn, us (code pays fourni par la source)

1 citation Therapeutics and Clinical Risk Management
Accès ouvert 2026 review OpenAlex

Maternal hypertension and survival without bronchopulmonary dysplasia in preterm infants: a meta-analysis of cohort studies

Siyi Wang, Huan Yu, Changyi Li, Lijuan Luo et autres

The association between hypertensive disorders of pregnancy (HDP) and bronchopulmonary dysplasia (BPD) in preterm infants remains controversial due to inconsistent findings in previous studies. However, systematic studies and meta-analyses evaluating the association remain limited. The study followed the Meta-analysis of Observational Studies …

0 citations Figshare
Accès ouvert 2026 review OpenAlex

Maternal hypertension and survival without bronchopulmonary dysplasia in preterm infants: a meta-analysis of cohort studies

Siyi Wang, Huan Yu, Changyi Li, Lijuan Luo et autres

The association between hypertensive disorders of pregnancy (HDP) and bronchopulmonary dysplasia (BPD) in preterm infants remains controversial due to inconsistent findings in previous studies. However, systematic studies and meta-analyses evaluating the association remain limited. The study followed the Meta-analysis of Observational Studies …

0 citations Figshare
Accès ouvert 2026 review OpenAlex

Maternal hypertension and survival without bronchopulmonary dysplasia in preterm infants: a meta-analysis of cohort studies

Siyi Wang, Huan Yu, Changyi Li, Lijuan Luo et autres

BACKGROUND: The association between hypertensive disorders of pregnancy (HDP) and bronchopulmonary dysplasia (BPD) in preterm infants remains controversial due to inconsistent findings in previous studies. However, systematic studies and meta-analyses evaluating the association remain limited. METHODS: The study followed the Meta-analysis of …

cn (code pays fourni par la source)

0 citations The Journal of Maternal-Fetal & Neonatal Medicine
Accès ouvert 2026 article OpenAlex

Impact of Different Maternal Age Subgroups on Pregnancy Adverse Outcomes in China: A Multicenter Cohort Study

Yi‐Jie Zhang, Jianguo Zhou, Chao Chen

ABSTRACT Background and Aims To analyze the distribution pattern of maternal age and the impact of different maternal age subgroups on pregnancy adverse outcomes in China. Methods This is a multicenter retrospective cohort study from 2010 to 2017. Live‐born singletons were included. …

cn (code pays fourni par la source)

0 citations Health Science Reports
Accès ouvert 2025 article OpenAlex

Prolonged recurrence-free survival by autologous rectronectin-activated killer (RAK) cells in resected high-risk hepatocellular carcinoma: an experimental single-arm phase II trial (pilot study)

Yiran Wang, Jing Fan Xu, Luyao Zhang, Jinlian Tong et autres

BACKGROUND: Hepatocellular carcinoma (HCC) is prone to recurrence following hepatectomy, posing significant clinical challenges. Our previous research suggested that adoptive T-cell therapy could improve the impaired liver microenvironment. This study aimed to evaluate the efficacy and safety of adjuvant RetroNectin-Activated Killer (RAK) …

cn (code pays fourni par la source)

3 citations International Journal of Surgery
2025 article OpenAlex

Circ_0044362 Facilitates the Progression of Epithelial Ovarian Cancer via Enhancing HOXB4 Transcription to Activate the RUNX1/IGFBP3 Axis

Shuqi Ye, Han Wu, Junjiang Liu, Jianguo Zhou et autres

Increasing numbers of studies have elucidated the emerging roles of circular RNA (circRNA) in cancer progression. However, the function of circRNAs in modulating their parental genes in ovarian cancer remains poorly understood. In this study, we identified that circ_0044362, a circRNA derived …

cn (code pays fourni par la source)

0 citations Molecular Carcinogenesis
Accès ouvert 2024 article OpenAlex

Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular Carcinoma

Xinyu Bi, Yinying Lu, Bo Chen, Zhengqiang Yang et autres

Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality; it ranks as the second most common cause of cancer deaths in China. Most HCC patients are first diagnosed at an advanced stage. In recent years, targeted therapy combined with immunotherapy has …

cn, us (code pays fourni par la source)

7 citations Liver Cancer
Accès ouvert 2024 article OpenAlex

Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update

Xinyu Bi, Haitao Zhao, Hong Zhao, Guangming Li et autres

Hepatocellular carcinoma (HCC) is a common malignancy in China, with high recurrence rate and low resection rate among patients first diagnosed. Preoperative treatments including neoadjuvant and conversion therapy have the potential to overcome these challenges. In December 2021, Chinese expert consensus on …

cn (code pays fourni par la source)

19 citations Liver Cancer
Accès ouvert 2023 article OpenAlex

Analysis of the posterior cerebral perfusion status and clinical prognostic value in chronic unilateral middle cerebral artery occlusion using SWAN combined with 3D-ASL

Jianguo Zhou, Guifen Li, Yun Meng, Fangyun Hu et autres

To investigate the predictive value of T2 star-weighted angiography (SWAN) combined with 3-dimensional (3D) arterial spin labeling (3D-ASL) to assess cerebral perfusion status and clinical prognosis in chronic unilateral middle cerebral artery (MCA) M1 occlusion. This study included 55 patients diagnosed with …

cn (code pays fourni par la source)

1 citation Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.